Realizing personalized prediction for the reversal of chronic hepatitis B-associated liver fibrosis through machine learning
Although long-term antiviral therapy can reverse liver fibrosis in a considerable proportion of patients with chronic hepatitis B, treatment response differs markedly among individuals, and reliable methods for predicting who will benefit remain lacking. Conventional clinical tools such as liver stiffness measurement a...